Investing.com - NuCana reported on Thursday second quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
NuCana announced earnings per share of £-0.0016 on revenue of £0.00. Analysts polled by Investing.com anticipated EPS of £-0.0016 on revenue of £0.00.
NuCana shares are down 74.62% from the beginning of the year, still down 81.81% from its 52 week high of £3.32 set on February 8. They are under-performing the Nasdaq which is down 21.27% from the start of the year.
NuCana follows other major Healthcare sector earnings this month
NuCana's report follows an earnings missed by Medtronic on May 26, who reported EPS of £1.52 on revenue of £8.09B, compared to forecasts EPS of £1.56 on revenue of £8.43B.
Cigna had beat expectations on May 6 with first quarter EPS of £6.01 on revenue of £44.11B, compared to forecast for EPS of £5.18 on revenue of £43.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar